Prashant Nighot

Associate Professor; #Intestine; #Leakygut; #Autophagy; #Tightjunctions; #GIPhysiology

[Prashant Nighot @NighotPLab]

As a GI and liver researcher, I always wonder why NIDDK do not offer R21 mechanism. Several colleagues mentioned that a lot of good science doesn’t get tested. This is particularly a good time to restart R21, as NIH is moving away from NOFO. @NIDDKgov @FriendsofNIDDK

[Prashant Nighot @NighotPLab]

@JonathanStineMD @KofiClarkeMD @PennStHershey Thanks @JonathanStineMD and @KofiClarkeMD ! Thanks to @AGA_GHAdvances for a great publication experience.

[Prashant Nighot @NighotPLab]

Looking forward to visit today the Vanderbilt Epithelial Biology Center @EBCVanderbilt, share our work and meet distinguished faculty @GoldenringLab and others.

[Jonathan G. Stine, MD MSc, FACP @JonathanStineMD]

👏 👏 👏 congrats @NighotPLab on your selection as the next Vice Chair of Research for @PennStHershey DOM! So lucky to have you as a collaborator and friend! Well done!

[Prashant Nighot @NighotPLab]

@JonathanStineMD @PennStHershey Thanks so much @JonathanStineMD Always proud for your impactful research!

[Prashant Nighot @NighotPLab]

Great talks including Dr. Jerry Turner and @KofiClarkeMD

[Kofi Clarke MD @KofiClarkeMD]

Afternoon session starts with IBD surgeon extraordinaire @HolubarStefan from Cleveland Clinic

[Prashant Nighot @NighotPLab]

Looking forward for the Inflammatory Bowel Disease (IBD) Research Symposium https://t.co/zN254WCxeO via @PennStHershey with guest speakers Dr. Jerry Turner from Harvard and @HolubarStefan, and the Penn State experts @KofiClarkeMD and Drs. Coates, Yochum, Pinchuk, and others.

[Prashant Nighot @NighotPLab]

@CellReports We showed novel regulation of Tight Junction barrier by activation of two important pathways...Great experience with constructive reviews and rigorous but very helpful editing and publishing process. Thanks @CellReports @AKSubramenium @KushalS81193480

[Prashant Nighot @NighotPLab]

Looking forward for a day full of IBD research including talks from Dr. Sean Colgan from Uni of Colorado and Dr. Ravinder Gill from UIC @Ravgill07
Inflammatory Bowel Disease (IBD) Research Symposium https://t.co/zN254WTAgO via @PennStHershey

[Prashant Nighot @NighotPLab]

So much of great basic, translational, and clinical science @DDWMeeting. Feel exhausted but inspired….

[Meghali Thakre Nighot @MeghaliThakre]

Looking forward for two great talks on Autophagy and TJ proteins from @NighotPLab (Research forum in room 27 on 5/23/22 starting at 8.00)

[Prashant Nighot @NighotPLab]

Congratulations, Dr. Krashnewski @jlkrasch for being a new Director of @PennStateCTSI. Sure, you will do wonders for clinical and translational research at @PSHResearch.

[Prashant Nighot @NighotPLab]

@kocilab Disheartening….but very well said

[Prashant Nighot @NighotPLab]

Our new paper in Autophagy:
AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation and reduces intestinal epithelial tight junction permeability https://t.co/SsxfloWzlI
Thank you @vpderetic and @AIM_autophagy for help on initiating this project.

[Prashant Nighot @NighotPLab]

@YatrikShahLab @Hannah_N_Bell @RyanRebernick @JoshuaGoyert Great, congratulations

[Prashant Nighot @NighotPLab]

Please join us #DDW2021 @AmerGastroAssn for a session on gut barrier in health and disease, May 22nd, 5.30-7 PM.

[Prashant Nighot @NighotPLab]

Check out latest developments on gut fibrosis #DDW2021 and @AmerGastroAssn May 22nd, Saturday, 10-11.30 AM

[Prashant Nighot @NighotPLab]

Great talk today @SundrudL , nice mix of gut physiology and immunology.

[Prashant Nighot @NighotPLab]

Beth always supported junior scientists, including me. Huge loss for science and Autophagy field in particular.

[The AIM Center @AIM_autophagy]

We are deeply saddened by the news of Dr. Beth Levine's passing. Our deepest condolences to Beth's family, friends, and colleagues. Please take a few moments to read the memoriam:
https://t.co/Gb0OwTF8sJ

[Prashant Nighot @NighotPLab]

@GIStressBioLab @NICHD_NIH @RobisonLabMSU Wonderful. Congratulations, Adam.